Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Opsens Inc T.OPS

Alternate Symbol(s):  OPSSF

OpSens Inc. is engaged in physiological measurements such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and in transcatheter aortic valve replacement (TAVR) in the structural heart market. The Company supplies an optical-based pressure guidewire (OptoWire), a guidewire used in the TAVR procedure (SavvyWire) and a wide range of miniature optical sensors to measure pressure and temperature to be used in a wide range of applications that can be integrated into other medical devices.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 


100% agree. A big bank has a lot invested in them.  rate and reply


Excellent temps d'acheter ce matin avant les resultats du quatrieme trimestre  rate and reply


Pink has enough capital to get them through their trial stage. That cash comes from a big investment social capital. The company will not go under at all. Their technology is far to valuable. They more


Both companies are excellent choices, and both companies will succeed. Pink is such a new company in its infancy stage right now. You can forget all the numbers related to their financials for more


What are your thoughts on Perimeter Medical Imaging AI versus Opsens at this time? Which do you prefer? PINK has marginal revenue, losses, negative cash flow and not much cash. It has some more

RE:RE:8 was never a thing

We'll yes your correct, that was posted a year ago and they also had a $10 price target. We're talking recently/current projections are $6 dollar price targets  rate and reply

RE:8 was never a thing

8 is a thing... for 2025 A CFA produced a research report on seeking Alpha and has had an 8$ target for a long time. more

8 was never a thing

Guys forget 8 dollars it was never a thing. It was misinterpreted. According to our friend Rahul, he has had a 6 dollar target for over a year now. I really don't think JNJ has any interest more


Is showing no change to this post from 8 Sep. Best to stick to C$6.00 which already seems to be the high on the street. Aside from energy, nice to see OPS as one of a relatively few in the green more

Price target

The price target of 8 dollars was once talked about here. I don't know where that number comes from, I think it's misinterpreted.   rate and reply

RE:RE:RE:New Target Price

More likely the $6 is U.S.  rate and reply

RE:RE:New Target Price

On the Cantech letter yesterday it is written that the price target is 6$ but on  TD Webbroker if you go in the research page and look for ops then go to the  analyst page  you see more

RE:New Target Price

Curious that only last week he had a $6 target . Wonder what lead such a sizeable bump ?   rate and reply

New Target Price

Rahul Sarugaser at Raymond James put out a new target price at $8.22 . Encouraging!  rate and reply


This company does look and sound promising. Iam a shareholder like many others here. I would have no idea what price the company would be bought out at. If that happens. I'm not really sure why more


In all likelihood it wasn't his decision to step down from his position. He was probably givin the opportunity to step down or get fired/relieved from his position. The company clearly wants more

Why ?

OPSENS ANNOUNCES DEPARTURE OF CFO Robin Villeneuve, chief financial officer and corporate secretary of Opsens Inc., will be leaving the company on Dec. 9, 2022, to pursue other more

RE:Spare money Raymond James repeats the RBC comment on JNJ. Also Edwards ,generally regarded as a growth company, reported essentially a no growth quarter which might make them more motivated more

RE:Spare money

I sure hope its not taken out for 400 millions because with around 110 milions shares outstanding it's $3.63  per share,even at 500 M its $4.54 per share.  rate and reply